Skip to content
PoliticalRepoPoliticalRepo

United States · Resolution · HCONRES

H.Con.Res. 17 (107th)

Expressing the sense of the Congress supporting Federal funding of pluripotent stem cell research.

openUnited States· United States Congress· EN

Introduced

30 January 2001

Last action

11 July 2001 · Introduced

Status

Sponsor introductory remarks on measure. (CR H3871)

Sponsors

Rep. Maloney, Carolyn B. [D-NY-12], Rep. Morella, Constance A. [R-MD-8], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Gilman, Benjamin A. [R-NY-20], Sen. Udall, Mark [D-CO], Rep. Woolsey, Lynn C. [D-CA-6], Rep. Thurman, Karen L. [D-FL-5], Rep. Berkley, Shelley [D-NV-1], Rep. Evans, Lane [D-IL-17], Rep. Price, David E. [D-NC-4], Rep. Frank, Barney [D-MA-4], Rep. Hooley, Darlene [D-OR-5], Rep. Hilliard, Earl F. [D-AL-7], Rep. Dooley, Calvin M. [D-CA-20], Rep. Waxman, Henry A. [D-CA-33], Rep. Capuano, Michael E. [D-MA-8], Rep. Hinchey, Maurice D. [D-NY-22], Rep. Miller, George [D-CA-11], Rep. Stark, Fortney Pete [D-CA-13], Rep. Schakowsky, Janice D. [D-IL-9], Rep. McGovern, James P. [D-MA-2], Rep. Rivers, Lynn N. [D-MI-13], Rep. Doggett, Lloyd [D-TX-37], Rep. Pelosi, Nancy [D-CA-11], Rep. Matsui, Robert T. [D-CA-5], Rep. McCarthy, Karen [D-MO-5], Rep. Rangel, Charles B. [D-NY-15], Rep. Clay, Wm. Lacy [D-MO-1], Rep. Nadler, Jerrold [D-NY-12], Rep. McDermott, Jim [D-WA-7], Rep. Allen, Thomas H. [D-ME-1], Rep. Wexler, Robert [D-FL-19], Rep. Sherman, Brad [D-CA-32], ROBERT BRADY, Rep. Harman, Jane [D-CA-36], Rep. Pascrell, Bill, Jr. [D-NJ-9], Sen. Kirk, Mark Steven [R-IL], Rep. Pryce, Deborah [R-OH-15], Rep. Lantos, Tom [D-CA-12], Rep. Smith, Adam [D-WA-9], Rep. Millender-McDonald, Juanita [D-CA-37], Rep. Deutsch, Peter [D-FL-20], Rep. Berman, Howard L. [D-CA-28], Sen. Baldwin, Tammy [D-WI], Rep. Roybal-Allard, Lucille [D-CA-40], Rep. Kilpatrick, Carolyn C. [D-MI-13], Rep. Tierney, John F. [D-MA-6], Rep. Thompson, Mike [D-CA-4]

Subjects

Healthcare

Source updated

2 January 2025

Healthcare

Summary

Expresses support for Federal funding of pluripotent stem cell research.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 30 January 2001

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 30 January 2001

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 30 January 2001

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 14 February 2001

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 11 July 2001

    Introduced

    Sponsor introductory remarks on measure. (CR H3871)

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 30 January 2001

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 30 January 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 30 January 2001

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 87 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.